Stock Events

Alnylam Pharmaceuticals (DUL.F) Q4 2023 Earnings

2NovConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-2.02
-0.8
0.42
1.64

Details

Expected EPS
-1.2433872000000001
Actual EPS
1.6390104
Surprise EPS
2.88
Surprise Percent
+231.82%

Description

Alnylam Pharmaceuticals (DUL.F) has reported earnings of 1.6390104 per share for Q4 2023.

0 Comments

Share your thoughts